Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Sona Nanotech Inc C.SONA

Alternate Symbol(s):  SNANF

Sona Nanotech Inc. is a nanotechnology life sciences company, which is engaged in developing targeted hyperthermia therapy. The Company has developed multiple methods for the manufacturing of various types of gold nanoparticles (GNR). It is engaged in research and development of its technology for use in multiplex diagnostic testing platforms and advanced biomedical applications. Its gold... see more

CSE:SONA - Post Discussion

Sona Nanotech Inc > Not so fast!
View:
Post by Frankensteinnow on Jan 14, 2021 3:21pm

Not so fast!

https://www.msn.com/en-ca/news/world/qiagen-warns-against-using-standard-tests-to-track-coronavirus-variants/ar-BB1cKZJX?ocid=AMZN
Comment by dart321 on Jan 14, 2021 4:09pm
yup it's a big problem alright. Here is the big positive for Sona it detects the spike particle while all the rest detect the "n" particle. These new strains have more spikes so wouldn't you think the sona test would work better?
Comment by nodeals on Jan 14, 2021 4:39pm
From SONA FAQ tab in Investor tab; Is the Sona test affected by a recent mutation of the virus identified in the UK?   The recent mutation relates to a change in the gene sequence of a section of the S2 protein called the Receptor Binding Domain (RBD), which is responsible for the virus’s ability to enter cells. The Sona test identifies the presence of spike proteins in a sample through ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities
USER FEEDBACK SURVEY ×

Be the voice that helps shape the content on site!

At Stockhouse, we’re committed to delivering content that matters to you. Your insights are key in shaping our strategy. Take a few minutes to share your feedback and help influence what you see on our site!

The Market Online in partnership with Stockhouse